
|Articles|March 1, 2004
Burn cream sold
Human BioSystems (HBS), a Palo Alto, Calif., biomedical company conducting research to extend the shelf life of blood platelets and donor organs, announced that it finalized a purchase agreement to acquire all rights to a skin-cream product previously developed for severe burns.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
5

















